On Wednesday, the Centers for Medicare & Medicaid Services (CMS) released its proposed calendar year 2025 physician fee schedule, which includes recommendations on coverage of digital health tools, including digital therapeutics and telehealth services.
To support access to behavioral health services, CMS proposed that Medicare pay for digital mental health treatment devices used in...
The digital health sector had a huge funding year in 2021, with Silicon Valley Bank reporting health tech companies scored nearly $40 billion, double 2020's total.
As more of these companies move out of the growth stages, how will healthcare providers get reimbursed for using their technologies? And what's the state of the reimbursement landscape right now?
"So I would typify it as better than...
Pear Therapeutics announced Wednesday that Massachusetts’ Medicaid program plans to cover its digital prescription therapeutics for treating substance and opioid use disorders, reSET and reSET-O.
The decision to cover the digital therapeutics under MassHealth is subject to federal and state approval as well as the availability of funding.
“We applaud MassHealth for their leadership in introducing...
Those keeping an eye on the digital therapeutics industry over the last several years likely remember the name Dthera Sciences.
The startup and its CEO Ed Cox became one of the developing space's many standard bearers around 2018. During that timeframe it landed a Breakthrough Device designation from the FDA for its Alzheimer's symptoms treatment, with Cox chairing a handful of industry...
About the author: Dr. Liz Kwo is currently the staff VP of clinical data analytics at Anthem and a faculty lecturer at Harvard Medical School who previously cofounded and served as CEO of telemedicine second opinion company InfiniteMD. She received an MD from Harvard Medical School, an MBA from Harvard Business School and an MPH from the Harvard T.H. Chan School of Public Health.
Digital health...
Abbott announced yesterday that its recently cleared FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system is now covered by the Centers for Medicare and Medicaid Services (CMS), and available to Medicare beneficiaries with diabetes who meet eligibility criteria.
Indicated for diabetes management in patients aged four years or older, the updated version of Abbott's system can...
Virtual reality has been on the healthcare scene for quite a few years now, but it’s only within the last half decade or so that the technology has started to resemble an effective medical technology. While its potential use cases are varied to say the least, a couple of standout approaches such as pain distraction therapy now boast a healthy body of data suggesting its prowess under experimental...
Many healthcare and digital health stakeholders don’t believe that health tech companies fully understand the complexities of their market, according to a new survey published this week from law firm Ropes & Gray and media company Crain’s New York Business.
These data from nearly 300 respondents also suggest apprehensions surrounding healthcare partnerships with digital health companies, with...
In many respects, the pharma industry’s operations are still in the early stages of technological revolution, and there’s no better example of this than its gradual adoption of digital health and digital therapeutics.
On one hand, more and more groups are regularly striking new partnerships that supplement existing drug treatments with digital tools, while Novartis continues its work with Pear...
About the author: Paddy Padmanabhan is founder and CEO of Damo Consulting, a growth strategy and digital transformation advisory firm that works with healthcare enterprises and global technology companies, and author of The Big Unlock: Harnessing Data and Growing Digital Health Businesses in a Value-Based Era.
Recent data from VC firm Rock Health on digital health funding numbers point to a...
